ClassID:

20918

A61K38/1709 - page 16 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#4501
20090214431
2009-08-27

Identification methods for ergothioneine transporter modulators and therapeutic uses thereof

#4502
20090210956
2009-08-20

COMPOSITION AND METHOD FOR CLUSTERIN-MEDIATED STEM CELL THERAPY FOR TREATMENT OF ATHEROSCLEROSIS AND HEART FAILURE

#4503
20090209473
2009-08-20

Componds and methods for pormoting angiogenesis

#4504
20090208524
2009-08-20

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

#4505
20090208484
2009-08-20

R-SPONDIN COMPOSITIONS AND METHODS OF USE THEREOF

#4506
20090203878
2009-08-13

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

#4507
20090203134
2009-08-13

REMEDY FOR NERVE CELL REGENERATION

#4508
20090202555
2009-08-13

Antibodies against a peptide epitope of apolipoprotein B

#4509
20090202523
2009-08-13

Antibodies against a peptide epitope of apoliprotein B

#4510
20090202490
2009-08-13

Mutant adeno-associated virus virions and methods of use thereof

#4511
20090202475
2009-08-13

Compositions and methods for treatment of microbial disorders

#4512
20090197808
2009-08-06

Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease

#4513
20090197256
2009-08-06

Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems

#4514
20090196878
2009-08-06

Intestinal epithelial glucose sensor

#4515
20090192115
2009-07-30

USE OF COMPOUNDS THAT INTERFERE WITH THE HEDGEHOG SIGNALING PATHWAY FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTING, INHIBITING, AND/OR REVERSING OCULAR DISEASES RELATED WITH OCULAR NEOVASCULARIZATION

#4516
20090192085
2009-07-30

FKBP-L and uses thereof

#4517
20090192082
2009-07-30

CXCR4 ANTAGONIST TREATMENT OF HEMATOPOIETIC CELLS

#4518
20090192081
2009-07-30

Casein derived peptides and uses thereof

#4519
20090192076
2009-07-30

RECOMBINANT VWF FORMULATIONS

#4520
20090191570
2009-07-30

Inhibition of Interaction of PSD93 and PSD95 with nNOS and NMDA Receptors

#4521
20090191237
2009-07-30

Methods and reagents for vaccination which generate A CD8 T cell immune response

#4522
20090191231
2009-07-30

Prevention and treatment of amyloidogenic disease

#4523
20090191202
2009-07-30

Methods for manipulating phagocytosis mediated by CD47

#4524
20090186816
2009-07-23

Polypeptide targeting to mitochondria

#4525
20090186808
2009-07-23

Method for the treatment of valvular disease

#4526
20090186806
2009-07-23

Truncated Activin Type II Receptor and Methods of Use

#4527
20090186803
2009-07-23

USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID, SPHINGOLIPID AND CHOLESTEROL.

#4528
20090186801
2009-07-23

Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells

#4529
20090185997
2009-07-23

Methods of suppressing microglial activation and systemic inflammatory responses

#4530
20090185982
2009-07-23

Approach to the treatment of compartment syndrome

#4531
20090181882
2009-07-16

METHODS AND PREPARATIONS FOR CURING CRITICALLY ILL PATIENTS

#4532
20090175853
2009-07-09

Method for treating amyloid disease

#4533
20090175836
2009-07-09

Prelamin A pre peptide as a universal stem cell differentiation signal

#4534
20090175797
2009-07-09

Inflammation-inhibitory serum factors and uses thereof

#4535
20090170779
2009-07-02

F11 receptor (F11R) antagonists as therapeutic agents

#4536
20090170777
2009-07-02

HSP THERAPY IN CONJUNCTION WITH A LOW ANTIGENICITY DIET

#4537
20090170771
2009-07-02

Anti-angiogenic agents and methods of their use

#4538
20090169675
2009-07-02

Milk Derived Composition and Use to Enhance Muscle Mass or Muscle Strength

#4539
20090169614
2009-07-02

METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES

#4540
20090169598
2009-07-02

Treatment of bacterial infections

#4541
20090169559
2009-07-02

Parenteral formulations of peptides for the treatment of systemic lupus erythematosus

#4542
20090163413
2009-06-25

DENTAL PRODUCTS COMPRISING BONE GROWTH ENHANCING PEPTIDE

#4543
20090162362
2009-06-25

Alzheimer's disease treatment method

#4544
20090162357
2009-06-25

Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases

#4545
20090162338
2009-06-25

Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways

#4546
20090162320
2009-06-25

GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN

#4547
20090162296
2009-06-25

Approach to treat intraocular hypertension

#4548
20090156491
2009-06-18

METHODS OF INHIBITING ANGIOGENESIS WITH FRAGMENTS AND HOMOLOGS OF TROPONIN SUBUNIT I

#4549
20090155834
2009-06-18

Methods of NAD-dependent deacetylation of a lysine residue in a protein

#4550
20090155293
2009-06-18

Modified defensins and their use

#4551
20090155287
2009-06-18

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#4552
20090155277
2009-06-18

Use of immunesuppressant receptor

#4553
20090149412
2009-06-11

Method for Inhibition of Phospholamban Activity for the Treatment of Cardiac Disease and Heart Failure

#4554
20090149390
2009-06-11

Oxidant resistant apolipoprotein A-1 and mimetic peptides

#4555
20090149382
2009-06-11

Modulation of lipid rafts

#4556
20090149380
2009-06-11

Vasostatin as marrow protectant

#4557
20090149373
2009-06-11

Use of survivin to treat kidney failure

#4558
20090149371
2009-06-11

Treatment of neurological deficits in the striatum or substanta nigra pars compacta

#4559
20090148444
2009-06-11

Pharmaceutical composition for treating immune diseases

#4560
20090148442
2009-06-11

Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease

#4561
20090148427
2009-06-11

PLATELET GLYCOPROTEIN IB ALPHA FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

#4562
20090143277
2009-06-04

Nutritional composition for controlling blood sugar level

#4563
20090142360
2009-06-04

Use of ferritin to treat iron deficiency disorders

#4564
20090142342
2009-06-04

B7-H4 RECEPTOR AGONIST COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND AUTO-IMMUNE DISEASES

#4565
20090142336
2009-06-04

METABOLIC REGULATORS AND USES THEREOF

#4566
20090142334
2009-06-04

DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE

#4567
20090142312
2009-06-04

Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1

#4568
20090142311
2009-06-04

ENGINEERED INTERVERTEBRAL DISC TISSUE

#4569
20090137479
2009-05-28

METHODS OF TREATING AND DIAGNOSING LAMINOPATHY

#4570
20090137465
2009-05-28

NOVEL USE

#4571
20090137459
2009-05-28

Food Product for Enteral or Oral Nutrition

#4572
20090136575
2009-05-28

Protein formulation

#4573
20090136520
2009-05-28

Mitochondrial localization of MUC1

#4574
20090136496
2009-05-28

Chronic lymphocytic leukemia prognosis and treatment

#4575
20090136479
2009-05-28

Ubiquitin-like protein isg15 for hiv inhibition

#4576
20090131321
2009-05-21

Agents for reducing injury to mammalian cells

#4577
20090131315
2009-05-21

Treatment of subarachnoid hemorrhage with Apo E analogs

#4578
20090131309
2009-05-21

ICA512 COUPLES INSULIN SECRETION AND GENE EXPRESSION IN BETA-CELLS

#4579
20090124568
2009-05-14

Screening method for compounds that promote differentiation of inner ear progenitor cells

#4580
20090124564
2009-05-14

Compositions and methods for regulating apoptosis

#4581
20090118187
2009-05-07

Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto

#4582
20090118173
2009-05-07

TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASES

#4583
20090118158
2009-05-07

Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesity

#4584
20090117178
2009-05-07

Peptide epitopes of apolipoprotein B

#4585
20090117137
2009-05-07

PEPTIDE EPITOPES OF APOLIPOPROTEIN B

#4586
20090117119
2009-05-07

RTEF-1 variants and the use thereof for inhibition of angiogenesis

#4587
20090117099
2009-05-07

Extracellular histones as biomarkers for prognosis and molecular targets for therapy

#4588
20090117093
2009-05-07

Granulysin peptides and methods of use thereof

#4589
20090110756
2009-04-30

Methods and compositions related to PLUNC surfactant polypeptides

#4590
20090110661
2009-04-30

Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity

#4591
20090105183
2009-04-23

Pharmaceutical composition containing decoy and method of using the same

#4592
20090105127
2009-04-23

Methods for stabilizing corneal tissue

#4593
20090104706
2009-04-23

CYTOKINE RECEPTOR MODULATORS, METHOD OF IDENTIFYING SAME, AND METHOD OF MODULATING CYTOKINE RECEPTORS ACTIVITY WITH SAME

#4594
20090098529
2009-04-16

Methods for attenuating virus strains for diagnostic and therapeutic uses

#4595
20090098207
2009-04-16

Technology for the Preparation of Microparticles

#4596
20090098145
2009-04-16

METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA MODULATION OF MEGALIN ACTIVITY

#4597
20090098127
2009-04-16

Agents capable of downregulating an MSF-A dependent HIF-1α and use thereof in cancer treatment

#4598
20090092587
2009-04-09

Laminins, derivatives, and compositions including same and methods for their therapeutic use

#4599
20090092579
2009-04-09

NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID

#4600
20090092557
2009-04-09

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

#4601
20090088402
2009-04-02

Agent for inducing apoptosis comprising MSX1 or a gene encoding the same as an active ingredient

#4602
20090088399
2009-04-02

Use of Light Sensitive Genes

#4603
20090088382
2009-04-02

Use of the cathelicidin LL-37 and derivatives therof for wound healing

#4604
20090088364
2009-04-02

Pharmaceutical composition useful for the treatment of invasive pulmonary aspergillosis

#4605
20090082271
2009-03-26

AGENTS THAT REDUCE APOE-INDUCED IMPAIRMENT OF MITOCHONDRIA AND METHODS OF USE THEREOF

#4606
20090081189
2009-03-26

Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells

#4607
20090081184
2009-03-26

NON-PANCREATIC PROTEASES FOR CONTROLLING PLASMA CHOLECYSTOKININ (CCK) CONCENTRATION AND FOR TREATING PAIN

#4608
20090081183
2009-03-26

HIV Transcription Repressor Complex and Compositions and Methods Based Thereon

#4609
20090081125
2009-03-26

Method for screening substance having proangiogenic effect

#4610
20090076481
2009-03-19

Therapeutic angiogenesis for treatment of the spine

#4611
20090075921
2009-03-19

Bone/joint disease sensitivity gene and use thereof

#4612
20090075893
2009-03-19

Inhibition of angiogenesis by neutrophil alpha-defensins

#4613
20090075885
2009-03-19

ANTITUMOR EFFECT OF MUTANT BIK

#4614
20090075865
2009-03-19

Method for ameliorating dyskinesia

#4615
20090075377
2009-03-19

MOLECULAR INTERACTIONS IN CELLS

#4616
20090074893
2009-03-19

Antiviral peptides

#4617
20090074864
2009-03-19

Antimicrobial peptides with heparin binding activity

#4618
20090074795
2009-03-19

Methods for addressing ocular diseases through interference with the wnt signaling pathway

#4619
20090074754
2009-03-19

Methods and compositions useful in the treatment of mucositis

#4620
20090074668
2009-03-19

Vldlr-/- mouse models and related methods

#4621
20090069537
2009-03-12

Treatment of disease by inducing cell apoptosis

#4622
20090069234
2009-03-12

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

#4623
20090069231
2009-03-12

COMPOSITIONS AND METHODS FOR TREATING DIABETIC EYE DISEASE

#4624
20090069218
2009-03-12

Pharmaceutical compositions comprising casein derived peptides and methods of use thereof

#4625
20090068207
2009-03-12

Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease

#4626
20090068152
2009-03-12

GENE TRANSFER FOR REGULATING SMOOTH MUSCLE TONE

#4627
20090062785
2009-03-05

COMPOSITIONS AND METHODS FOR CANCER TREATMENT USING TARGETED SINGLE-WALLED CARBON NANOTUBES

#4628
20090062201
2009-03-05

INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES

#4629
20090062188
2009-03-05

Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same

#4630
20090060999
2009-03-05

Protein formulation

#4631
20090060902
2009-03-05

Methods and compositions for regulating T cell subsets by modulating transcription factor activity

#4632
20090054632
2009-02-26

Hydrophobically-modified protein compositions and methods

#4633
20090054342
2009-02-26

Peptides which bind to G protein-coupled receptors

#4634
20090054340
2009-02-26

Use of heat-shock protein 27 for cardiovascular disease prevention and treatment

#4635
20090054334
2009-02-26

Combinatorial improvement of bifunctional drug properties

#4636
20090054333
2009-02-26

Peptide inhibitors of cyclin-dependent kinase activity and uses thereof

#4637
20090054331
2009-02-26

High temperature stable peptide formulation

#4638
20090054313
2009-02-26

METHOD FOR INDUCING DEPOSITION AND MATURATION OF BONE COMPRISING A CO-THERAPEUTIC REGIMEN OF LMP-1 AND BMP-2

#4639
20090053734
2009-02-26

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

#4640
20090053311
2009-02-26

Pharmaceutical compositions for treating or preventing bone conditions

#4641
20090053254
2009-02-26

RECOMBINANT HUMAN ALPHA-FETOPROTEIN AS AN IMMUNOSUPPRESSIVE AGENT

#4642
20090053244
2009-02-26

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#4643
20090053198
2009-02-26

Cytokine induction of selectin ligands on cells

#4644
20090053190
2009-02-26

Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions

#4645
20090053186
2009-02-26

Therapy for primary and metastatic cancers

#4646
20090053171
2009-02-26

Treatment of cellular proliferative disorders

#4647
20090048165
2009-02-19

ANTI-HIV AGENT

#4648
20090048159
2009-02-19

KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE

#4649
20090048158
2009-02-19

Insulin-Like Growth Factor Binding Protein-4 Compounds and Methods for Inhibiting Angiogenesis and Tumor Growth in Mammalian Cells

#4650
20090048148
2009-02-19

COMPOSITIONS AND METHODS FOR THERAPEUTIC USE

#4651
20090047356
2009-02-19

TISSUE FACTOR COMPOSITIONS AND METHODS

#4652
20090047276
2009-02-19

METHODS FOR INCREASING CELL OR TISSUE REGENERATION IN A VERTEBRATE SUBJECT

#4653
20090047275
2009-02-19

Nell-1 enhanced bone mineralization

#4654
20090047240
2009-02-19

Chaperonin 10-induced immunomodulation

#4655
20090042807
2009-02-12

Oligopeptide treatment of ischemia reperfusion injury

#4656
20090042791
2009-02-12

INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES

#4657
20090042783
2009-02-12

APO E analogs and methods for their use

#4658
20090041745
2009-02-12

MODULATORS OF PARAPTOSIS AND RELATED METHODS

#4659
20090041735
2009-02-12

CD34 stem cell-related methods and compositions

#4660
20090036380
2009-02-05

Composition And Method For Brain Tumor Therapy

#4661
20090035874
2009-02-05

Methods for identifying agents for treating cardiovascular disease using inhibition of myeloperoxidase binding

#4662
20090029917
2009-01-29

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS & IMPAIRED LUNG FUNCTION & TO ENHANCE LYMPHOCYTE PRODUCTION

#4663
20090029909
2009-01-29

Modulation of synaptogenesis

#4664
20090029908
2009-01-29

Uteroglobin in the treatment of IGA mediated nephropathy

#4665
20090029400
2009-01-29

HIFαprolyl hydroxylation assay

#4666
20090028891
2009-01-29

Chlamydia Antigens and Uses Thereof

#4667
20090028816
2009-01-29

Treatment of depression, psychosis, and anxiety

#4668
20090028795
2009-01-29

NOD1 as an Anti-Tumor Agent

#4669
20090023662
2009-01-22

Identification of Agonistic Autoantibodies Associated with Humoral Kidney Rejection

#4670
20090023650
2009-01-22

Treatment of EGFR-dependent tumors by ABIN (a20 -binding inhibitor of NF kappab)

#4671
20090023637
2009-01-22

Methods for detecting and treating interstitial cystitis

#4672
20090022724
2009-01-22

Attractin/mahogany-like polypeptides

#4673
20090018312
2009-01-15

IGF-1 RECEPTOR INTERACTING PROTEINS

#4674
20090018078
2009-01-15

Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same

#4675
20090017558
2009-01-15

APOLIPOPROTEIN E STABLE FOLDING INTERMEDIATE AND METHODS OF USE THEREOF

#4676
20090012018
2009-01-08

Inhibition of pancretic cancer cell growth

#4677
20090011988
2009-01-08

Article of manufacture

#4678
20090011978
2009-01-08

Use of Surfactant Preparations for the Treatment of Surgical Adhesions

#4679
20090010952
2009-01-08

PHARMACEUTICAL COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT OR ERP57 TRANSLOCATION

#4680
20090010936
2009-01-08

Antibodies to Stra6 polypeptides

#4681
20090010935
2009-01-08

Compositions and Methods of Treating Tumors

#4682
20090010873
2009-01-08

Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis

#4683
20090005314
2009-01-01

Compositions and methods for modulating PGC-1α to treat huntington's disease

#4684
20090005305
2009-01-01

SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION

#4685
20090005302
2009-01-01

METHOD, APPARATUS, AND COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER

#4686
20090005296
2009-01-01

Ammonium/Ammonia Transporter

#4687
20090004211
2009-01-01

METHOD FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION

#4688
20090004181
2009-01-01

Method for modulating appetite

#4689
20090004178
2009-01-01

PHARMACEUTICAL COMPOUND FOR BLOCKING THE CRT OR ERP57 TRANSLOCATION

#4690
20090004145
2009-01-01

COMPOSITIONS AND METHODS INVOLVING GENE THERAPY AND PROTEASOME MODULATION

#4691
20080319173
2008-12-25

Blood group antigen fusion polypeptides and methods of use thereof

#4692
20080318840
2008-12-25

Compositions of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

#4693
20080317837
2008-12-25

Peptide epitopes of apolipoprotein B

#4694
20080312144
2008-12-18

Peptides for the treatment of herpes virus infections

#4695
20080311116
2008-12-18

Process for the determination of inflammatory processes and pharmaceutical compositions for the treatment thereof

#4696
20080311103
2008-12-18

Anti-Inflammatory Peptides and Methods of Use Thereof

#4697
20080306248
2008-12-11

Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof

#4698
20080305490
2008-12-11

AMPLIFICATION OF HUMAN MDM2 GENE IN HUMAN TUMORS

#4699
20080305102
2008-12-11

Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer

#4700
20080300183
2008-12-04

Gastrointestinal proliferative factor and uses thereof

#4701
20080299547
2008-12-04

Stra6 polypeptides

#4702
20080299135
2008-12-04

METHODS AND COMPOSITIONS FOR NERVE REGENERATION

#4703
20080299087
2008-12-04

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#4704
20080293652
2008-11-27

Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours

#4705
20080293633
2008-11-27

Pharmaceutical Formulations, Methods, and Dosing Regimens for the Treatment and Prevention of Acute Coronary Syndromes

#4706
20080293626
2008-11-27

Pigment epithelium-derived factor as a therapeutic agent for vascular leakage

#4707
20080293623
2008-11-27

ENRICHED HAPTOGLOBIN POLYMERS FOR THE TREATMENT OF DISEASE

#4708
20080290328
2008-11-27

Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog

#4709
20080287384
2008-11-20

Methods of Identifying Agents Having Antiangiogenic Activity

#4710
20080287369
2008-11-20

Compositions and Methods for Viscosupplementation

#4711
20080287358
2008-11-20

Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate CD4+ and CD8+ T cell immunity

#4712
20080287357
2008-11-20

Conjugate Comprising P21 Protein for the Treatment of Cancer

#4713
20080287341
2008-11-20

TREATMENT OF VASCULAR ABNORMALITIES USING NANOPARTICLES

#4714
20080286287
2008-11-20

Methods and Agents for Modulating Cellular Activity

#4715
20080286264
2008-11-20

Modulation of MUC1 activity

#4716
20080286247
2008-11-20

METHOD FOR SELECTIVELY TRANSDUCING PATHOLOGIC MAMMALIAN CELLS USING A TUMOR SUPPRESSOR GENE

#4717
20080286239
2008-11-20

COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS

#4718
20080286227
2008-11-20

Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases

#4719
20080280811
2008-11-13

Compositions and methods for treating vascular permeability

#4720
20080279919
2008-11-13

RLIP76 liposomes for protection against irradiation

#4721
20080279855
2008-11-13

Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical Compositions

#4722
20080275120
2008-11-06

LEUCINE RICH COMPOSITION

#4723
20080274993
2008-11-06

Methods and compositions for modulating vascular integrity

#4724
20080274966
2008-11-06

Biglycan and related therapeutics and methods of use

#4725
20080274170
2008-11-06

Peptide epitopes of apolipoprotein B

#4726
20080274077
2008-11-06

Method for Treating Neurological Disorders

#4727
20080269137
2008-10-30

Compositions and methods for modulating the immune system

#4728
20080269116
2008-10-30

Methods of Inhibiting Proinflammatory Cytokine Expression Using Ghrelin

#4729
20080269111
2008-10-30

Method of treating dyslipidemic disorder

#4730
20080268029
2008-10-30

Peptide epitopes of apolipoprotein B

#4731
20080267929
2008-10-30

Use of stem cells to generate inner ear cells

#4732
20080267875
2008-10-30

STEROID CONJUGATES, PREPARATION THEREOF AND THE USE THEREOF

#4733
20080263691
2008-10-23

Compositions and methods for regulating cardiac performance

#4734
20080261890
2008-10-23

Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions

#4735
20080261260
2008-10-23

USE OF GELSOLIN TO TREAT INFECTIONS

#4736
20080261218
2008-10-23

Detection of biomarkers for neuropsychiatric disorders

#4737
20080260756
2008-10-23

Peptide inhibitors of IASPP

#4738
20080260742
2008-10-23

Preventives/Remedies for Cancer

#4739
20080260736
2008-10-23

Methods and compositions to regulate iron metabolism

#4740
20080255643
2008-10-16

Compositions and methods relating to prevention of chemotherapy-induced alopecia

#4741
20080255050
2008-10-16

Method of treating atherosclerosis

#4742
20080255047
2008-10-16

Method of Treating Acute Renal Failure with Thrombomobulin Variant

#4743
20080254538
2008-10-16

Treatment of Neurological Deficits in the Striatum or Substanta Nigra Pars Compacta

#4744
20080254109
2008-10-16

LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM

#4745
20080249010
2008-10-09

Method Of Inducing Apoptosis In Lymphoid Cells

#4746
20080248024
2008-10-09

THERAPEUTIC AGENT FOR CANCER, INFLAMMATION, AND AUTO-IMMUNE DISEASE CONTAINING INHIBITOR OF ZINC FINGER PROTEIN 91

#4747
20080247956
2008-10-09

IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK

#4748
20080242609
2008-10-02

Composition for the therapy of diabetes mellitus and adiposity

#4749
20080242595
2008-10-02

Conjugate of insulin and vitamin B12 for oral delivery

#4750
20080241210
2008-10-02

Wound healing agent and composition

#4751
20080241194
2008-10-02

COMPOSITIONS AND METHODS FOR PROTECTING ORGANS, TISSUE AND CELLS FROM IMMUNE SYSTEM-MEDIATED DAMAGE

#4752
20080241169
2008-10-02

IMMUNIZATION AGAINST AMYLOID PLAQUES USING DISPLAY TECHNOLOGY

#4753
20080241135
2008-10-02

Methods for reducing viral load in HIV-1-infected patients

#4754
20080241125
2008-10-02

MUC1-IκB kinase complexes and their activities

#4755
20080241108
2008-10-02

Bone morphogenic protein binding peptide

#4756
20080241106
2008-10-02

Method for Preventing and Treating Diabetes Using Neurturin

#4757
20080234621
2008-09-25

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#4758
20080234393
2008-09-25

Compounds and methods for detection of carcinomas and their precursor lesions

#4759
20080234185
2008-09-25

Use of DMBT1 for capturing sulphate and phosphate group exposing agents

#4760
20080234180
2008-09-25

Use of sulglicotide for the treatment of mucositis

#4761
20080234178
2008-09-25

TAT-BH3 methods for treating arthritis

#4762
20080233645
2008-09-25

Methods and compositions of IG20 and DENN-SV splice variants

#4763
20080233085
2008-09-25

Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases

#4764
20080230465
2008-09-25

Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content

#4765
20080227738
2008-09-18

Compositions and methods for cell dedifferentiation and tissue regeneration

#4766
20080227726
2008-09-18

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#4767
20080227719
2008-09-18

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#4768
20080227718
2008-09-18

Prevention and treatment of amyloidogenic disease

#4769
20080227705
2008-09-18

Apoptosis-inducing agent and method for inducing apoptosis

#4770
20080227694
2008-09-18

Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain

#4771
20080227687
2008-09-18

COMPOSITION AND METHOD FOR CANCER TREATMENT USING TARGETED SINGLE-WALLED CARBON NANOTUBES

#4772
20080227195
2008-09-18

Expanding the eukaryotic genetic code

#4773
20080226706
2008-09-18

Use of repeat sequence protein polymers in personal care compositions

#4774
20080226599
2008-09-18

Methods of treatment involving p21/CIP1

#4775
20080221037
2008-09-11

Methods and compositions for treating disorders involving excitotoxicity

#4776
20080221036
2008-09-11

Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions

#4777
20080221027
2008-09-11

Composition and Methods for the Treatment of Duchene Muscular Dystrophy

#4778
20080221022
2008-09-11

Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis

#4779
20080220416
2008-09-11

Compositions for Inhibiting Cell Growth and Inducing Apoptosis in Cancer Cells and Methods of Use Thereof

#4780
20080214438
2008-09-04

Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content

#4781
20080214435
2008-09-04

Novel Cancer Indications of Mannan-Binding Lectin (Mbl) in the Treatment of Immunocompromised Individuals

#4782
20080214434
2008-09-04

Treatment of endothelial dysfunction in diabetic patients

#4783
20080213319
2008-09-04

CHEMOREPULSION OF CELLS

#4784
20080213223
2008-09-04

Systemic viral/ligand gene delivery system and gene therapy

#4785
20080213182
2008-09-04

Methods and compositions for treatment of myotonia

#4786
20080207489
2008-08-28

Use of CCN5 for treatment of smooth muscle proliferation disorders

#4787
20080207483
2008-08-28

Methods and compositions for diagnosis and therapy of cancer based on hyper-mutated tumor genes

#4788
20080206287
2008-08-28

Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands

#4789
20080206235
2008-08-28

COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE

#4790
20080206232
2008-08-28

Compositions and methods for modulating PGC-1β to treat lipid-related diseases and disorders

#4791
20080206201
2008-08-28

Recombinant Newcastle Disease Virus

#4792
20080200382
2008-08-21

Use of AIM3 acting as a tumor suppressor

#4793
20080200379
2008-08-21

Diagnostic markers of human female infertility

#4794
20080199512
2008-08-21

Oral Composition For Moisturizing Skin

#4795
20080199432
2008-08-21

Role for SRY in Parkinson's disease

#4796
20080194472
2008-08-14

Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation

#4797
20080193500
2008-08-14

Effect of LMP-1 overexpression on large and small proteoglycans of the disc

#4798
20080187961
2008-08-07

Polynucleotides encoding signal peptide-containing molecules

#4799
20080187512
2008-08-07

Treatment for spinal muscular atrophy

#4800
20080182779
2008-07-31

Apelin and uses thereof